Owen N. Witte

Active 1973–2024

215
Papers
45,824
Citations
132
h-index
214
i10-index

Citations

Citations per year for Owen N. Witte1974: 3 citations1975: 2 citations1976: 1 citations1977: 4 citations1978: 20 citations1979: 30 citations1980: 60 citations1981: 95 citations1982: 121 citations1983: 106 citations1984: 85 citations1985: 80 citations1986: 91 citations1987: 151 citations1988: 128 citations1989: 129 citations1990: 141 citations1991: 256 citations1992: 189 citations1993: 234 citations1994: 325 citations1995: 382 citations1996: 352 citations1997: 392 citations1998: 366 citations1999: 434 citations2000: 490 citations2001: 422 citations2002: 500 citations2003: 409 citations2004: 397 citations2005: 311 citations2006: 253 citations2007: 307 citations2008: 256 citations2009: 283 citations2010: 286 citations2011: 300 citations2012: 298 citations2013: 334 citations2014: 300 citations2015: 234 citations2016: 244 citations2017: 260 citations2018: 271 citations2019: 823 citations2020: 912 citations2021: 1,058 citations2022: 745 citations2023: 568 citations2024: 854 citations2025: 439 citations2026: 9 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,733 citing papers, 41.2% of this breakdownChina: 1,175 citing papers, 8.4% of this breakdownUnited Kingdom: 774 citing papers, 5.6% of this breakdownGermany: 735 citing papers, 5.3% of this breakdownJapan: 599 citing papers, 4.3% of this breakdownCanada: 568 citing papers, 4.1% of this breakdownItaly: 408 citing papers, 2.9% of this breakdownFrance: 388 citing papers, 2.8% of this breakdownSwitzerland: 315 citing papers, 2.3% of this breakdownAustralia: 304 citing papers, 2.2% of this breakdownNetherlands: 302 citing papers, 2.2% of this breakdownSpain: 209 citing papers, 1.5% of this breakdown
0%41.2%Other 17.2%

Fields

  • Medicine49.6%
  • Biochemistry, Genetics and Molecular Biology31%
  • Immunology and Microbiology12.5%
  • Engineering2.3%
  • Neuroscience1.9%
  • Chemistry0.6%
  • Other2.1%

Topics

  • Prostate Cancer Treatment and Research4.7%
  • Chronic Myeloid Leukemia Treatments3.5%
  • Chronic Lymphocytic Leukemia Research3.3%
  • Immune Cell Function and Interaction2.2%
  • T-cell and B-cell Immunology2.2%
  • Immunotherapy and Immune Responses2.1%
  • Other82%

Coauthors

All papers

Open in search
  1. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric J. Small - Journal of Clinical Oncology 2018 cited by 812

  2. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Chou, Haolong Li, Rajdeep Das, Hui Li, Ruhollah Moussavi-Baygi, Hani Goodarzi, Luke A. Gilbert, Primo N. Lara, Christopher P. Evans, Theodore C. Goldstein, Joshua M. Stuart, Scott A. Tomlins, Daniel E. Spratt, R. Keira Cheetham, Donavan T. Cheng, Kyle Kai‐How Farh, Julian Gehring, Jörg Hakenberg, Arnold Liao, Philip G. Febbo, John Shon, Brad Sickler, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, Felix Y. Feng - Cell 2018 cited by 759

  3. The DNA methylation landscape of advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, M. Yvonne Kim, Lawrence Fong, Daniel E. Spratt, Todd M. Morgan, Rohit Bose, Franklin W. Huang, Hui Li, Lisa N. Chesner, Tanushree Shenoy, Hani Goodarzi, Irfan A. Asangani, Shahneen Sandhu, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phillip G. Febbo, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Wilbert Zwart, J Costello, Jianhua Luo, Scott A. Tomlins, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Luke A. Gilbert, Paul C. Boutros, Kyle Kai‐How Farh, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, David A. Quigley, Felix Y. Feng - Nature Genetics 2020 cited by 353

  4. Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage

    Authors: , , , , , , , , , , , , , - Science 2018 cited by 362

  5. N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

    Authors: , , , , , , , , , , , , , , , - Cancer Cell 2016 cited by 415

  6. Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies

    Authors: , , , , , , , , , , - Cancer Cell 2019 cited by 186

  7. Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2023 cited by 72

  8. Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports Medicine 2021 cited by 104

  9. Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew J. Armstrong, Qing Cheng, Jiaoti Huang - Science Translational Medicine 2019 cited by 136

  10. Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 49

  11. Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Siwen Hu‐Lieskovan, Paula Kaplan‐Lefko, Satiro De Oliveira, Christopher S. Seet, Sarah Larson, Stephen J. Forman, James R. Heath, Jerome A. Zack, Gay M. Crooks, Caius G. Radu, Antoni Ribas, Donald B. Kohn, Owen N. Witte, Lili Yang - Cell stem cell 2019 cited by 97

  12. The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2023 cited by 72

  13. Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joshua M. Stuart, George Thomas, Felix Y. Feng, Eric J. Small, Joel A. Yates, Zheng Xia, Joshi J. Alumkal - Nature Communications 2022 cited by 59

  14. Migration to Apoptotic “Find-me” Signals Is Mediated via the Phagocyte Receptor G2A

    Authors: , , , , , , , - Journal of Biological Chemistry 2007 cited by 254

  15. The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Lloyd, Tierney Phillips, Erin McCarthy, Michael C. Haffner, Amina Zoubeidi, Matti Annala, Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, Lawrence Fong, Rohit Bose, Franklin W. Huang, Jianhua Luo, Anders Bjartell, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phuoc T. Tran, Edwin M. Posadas, Chuan He, Xiaolong Cui, Jiaoti Huang, Wilbert Zwart, Luke A. Gilbert, Christopher A. Maher, Paul C. Boutros, Kim N., Alan Ashworth, Eric J. Small, Housheng Hansen He, Alexander W. Wyatt, David A. Quigley, Felix Y. Feng - Cancer Research 2022 cited by 67

  16. T cell antigen discovery via trogocytosis

    Authors: , , , , , , , , , , , , , , , - Nature Methods 2019 cited by 162

  17. IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 49

  18. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia

    Authors: , , , , , , , , , , , , , - Cell 1993 cited by 1,346

  19. Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zheng Xia - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 169

  20. Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Owen N. Witte, David Baltimore, James S. Economou, Antoni Ribas - Clinical Cancer Research 2014 cited by 253

  21. Systemic surfaceome profiling identifies target antigens for immune-based therapy in subtypes of advanced prostate cancer

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 157

  22. Activation of GPR4 by Acidosis Increases Endothelial Cell Adhesion through the cAMP/Epac Pathway

    Authors: , , , , , - PLoS ONE 2011 cited by 149

  23. Identification of a Cell of Origin for Human Prostate Cancer

    Authors: , , , , - Science 2010 cited by 563

  24. Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2016 cited by 239